Skip to main content

Table 5 Variables associated with high-dose prescribing

From: Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study

Variable

Antipsychotic

Antidepressant

Crude OR

(95% CI)

a Adjusted OR

(95% CI)

Crude OR

(95% CI)

Adjusted OR

(95% CI)

Age

1.0 (0.9,1.0)

1.0 (0.9,1.0)

1.0 (1.0,1.0)

1.0 (1.0,1.1)

Gender

 Reference = Male

0.6 (0.2,1.5)

0.6 (0.2,1.6)

2.5* (1.1,5.4)

2.2 (1.0,4.9)

Geographic location

 Reference = Metropolitan

1.0 (0.4,2.6)

1.2 (0.5,3.3)

1.7 (0.8,3.3)

1.8 (0.9,3.8)

Mental illnesses

 Reference = one condition

1.3 (0.5,3.3)

1.3 (0.4,3.6)

0.8 (0.4,1.7)

0.9 (0.4,2.2)

Admission (last 6 months)

 Reference = Yes

0.8 (0.3,2.4)

0.7 (0.2,2.4)

1.5 (0.7,3.2)

1.3 (0.6,3.0)

Prescriber

 Reference = GP only

1.0 (1.0,1.0)

1.0 (1.0,1.0)

1.0 (1.0,1.0)

1.0 (1.0,1.0)

 Psychiatrist only

4.6* (1.4,14.6)

4.5* (1.3,14.8)

2.6* (1.1,6.5)

2.7* (1.0,7.0)

bMultiple prescribers

2.5 (0.8,8.3)

1.9 (0.5,6.7)

1.7 (0.8,3.7)

1.6 (0.7,3.9)

  1. *p< 0.05, **p< 0.001 ; OR, odds ratio; CI, confidence interval; GP, general practitioner
  2. aAll variables were included in the adjusted models
  3. bMultiple prescribers consisted of GP and psychiatrist, GP and hospital doctor, or psychiatrist, hospital doctor and nurse practitioner